These findings indicate that phytoestrogens, naringenin and resveratrol, are sufficient to increase DAXX protein in ER+ breast cancer cells without stimulating total tumor cell proliferation or significantly activating classical ER signaling. The gene discussed is ESR1; the disease is neoplasm.